Literature DB >> 2923363

The measurement of inspiratory muscle strength by sniff esophageal, nasopharyngeal, and mouth pressures.

N Koulouris1, D A Mulvey, C M Laroche, E H Sawicka, M Green, J Moxham.   

Abstract

Sniff esophageal pressure (Pes) is a useful measurement of global inspiratory muscle strength, although it does require passage of an esophageal balloon. We investigated the relationship between nasopharyngeal pressure (Pnp) or pressure within the mouth (Pmo) and Pes during a maximal sniff from FRC without a noseclip. We measured Pes, Pnp, and Pmo simultaneously in 10 normal volunteers, and in 12 patients with inspiratory muscle weakness. In both groups, Pnp and Pmo were slightly less but very close to Pes. In normal volunteers, the mean ratio Pnp/Pes was 0.92 +/- 0.006 (mean +/- SE) and Pmo/Pes was 0.95 +/- 0.006. Regression analysis showed Pes = 4.57 + 1.05 Pnp (r = 0.995, p less than 0.001) and Pes = 0.74 + 1.05 Pmo (r = 0.994, p less than 0.001). Similar relationships between Pnp, Pmo, and Pes were found over a wide range of pressures generated by submaximal sniffs in normal subjects. In patients, the mean ratio Pnp/Pes was 0.90 +/- 0.02 and Pmo/Pes was 0.87 +/- 0.03. Regression analysis showed Pes = 5.12 + 1.0 Pnp (r = 0.949, p less than 0.001) and Pes = 11.2 + 0.882 Pmo (r = 0.936, p less than 0.001). We conclude that Pnp and Pmo predict Pes during a maximal sniff in both normal subjects and in patients with inspiratory muscle weakness. Sniff Pnp and/or Pmo may provide a useful and less invasive method of measuring maximal inspiratory pressures during a sniff.

Entities:  

Mesh:

Year:  1989        PMID: 2923363     DOI: 10.1164/ajrccm/139.3.641

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  15 in total

Review 1.  Assessment of respiratory muscle function and strength.

Authors:  N Syabbalo
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

Review 2.  Neurological complications of severe illness and prolonged mechanical ventilation.

Authors:  C M Wiles
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

3.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

Review 4.  Measurement of respiratory muscle strength.

Authors:  M I Polkey; M Green; J Moxham
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

5.  Inspiratory muscle relaxation rate assessed from sniff nasal pressure.

Authors:  D Kyroussis; G Mills; C H Hamnegard; S Wragg; J Road; M Green; J Moxham
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

6.  Measurement of sniff nasal and diaphragm twitch mouth pressure in patients.

Authors:  P D Hughes; M I Polkey; D Kyroussis; C H Hamnegard; J Moxham; M Green
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

Review 7.  Respiratory aspects of neurological disease.

Authors:  M I Polkey; R A Lyall; J Moxham; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

8.  The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis.

Authors:  P Rieder; M Louis; P Jolliet; J C Chevrolet
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

9.  Normal range for transdiaphragmatic pressures during sniffs with catheter mounted transducers.

Authors:  S A Evans; L Watson; A J Cowley; I D Johnston; W J Kinnear
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

10.  Respiratory disease in systemic lupus erythematosus: correlation with results of laboratory tests and histological appearance of muscle biopsy specimens.

Authors:  S A Evans; N D Hopkinson; W J Kinnear; L Watson; R J Powell; I D Johnston
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.